Monday, June 26, 2017
New Drug for Parkinson Disease Approved by FDA
The U.S. Food and Drug Administration announced three months ago that it has approved a new drug, Xadago, for the treatment of Parkinson's disease. This is indeed good news for me and other care givers with their love ones suffering from PD.
Roughly 50,000 Americans are diagnosed with Parkinson's disease each year and about 1 million people have have it, according to the National Institutes of Health. Xadago, or safinamide, is an add-on treatment for patients with Parkinson's disease who are taking levodopa, carbidopa or a combination of both and are experiencing times when their medications are not working well, also known as "off" episodes. For details read: